Gallstone disease primary prevention

Jump to navigation Jump to search

Gallstone disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gallstone disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Lithotripsy
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gallstone disease primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gallstone disease primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gallstone disease primary prevention

CDC on Gallstone disease primary prevention

Gallstone disease primary prevention in the news

Blogs on Gallstone disease primary prevention

Directions to Hospitals Treating Gallstone disease

Risk calculators and risk factors for Gallstone disease primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Effective measures for the primary prevention of gallstone disease include diet with sufficient fat and protein, maintaining a low body weight, and avoiding prolonged fasting.

Primary Prevention

Effective measures for prevention of gallstone disease include:[1][2][3][4]

References

  1. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC (1990). "Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans". Surg Gynecol Obstet. 170 (1): 25–31. PMID 2104681.
  2. Valdivieso V, Covarrubias C, Siegel F, Cruz F (1993). "Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium". Hepatology. 17 (1): 1–4. PMID 8423030.
  3. Quigley EM, Marsh MN, Shaffer JL, Markin RS (1993). "Hepatobiliary complications of total parenteral nutrition". Gastroenterology. 104 (1): 286–301. PMID 8419252.</ref *Daily injections of cholecystokinin or high doses of crystalline amino acids may promote gallbladder emptying and clearance of sludge in those on prolonged TPN *Patients with biliary sludge may benefit from prohylactic bile acid therapy<ref name="pmid9499324">Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC (1998). "The relation of physical activity to risk for symptomatic gallstone disease in men". Ann. Intern. Med. 128 (6): 417–25. PMID 9499324.
  4. Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC (1998). "The relation of physical activity to risk for symptomatic gallstone disease in men". Ann. Intern. Med. 128 (6): 417–25. PMID 9499324.

Template:WH Template:WS